AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7867114
Drug: Nicardipine hydrochloride,
RxNorm normalized name: NiCARdipine Hydrochloride, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine hydrochloride, 0.03 mg.kg‐1 iv
Trial: 7867114
Drug: Verapamil hydrochloride,
RxNorm normalized name: Verapamil Hydrochloride, 80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil hydrochloride, 0.1 mg.kg‐1 iv
Trial: 2765348
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 15 mg plus clonidine 1 ml (150 micrograms)
Trial: 2765348
Drug: 0.5% isobaric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% isobaric bupivacaine 15 mg plus isotonic saline 1 ml
Trial: 49560
Drug: Self-administered nitrous
RxNorm normalized name: Nitrous Oxide
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered nitrous oxide 50%/oxygen 50% ('Entonox' analgesic apparatus)
Trial: 23222003
Drug: Intracoronary nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary nitroglycerin (250-μg)
Trial: 23222003
Drug: Intracoronary diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary diltiazem (5-mg)
Trial: 11138763
Drug: Listeners making
RxNorm normalized name: MASK
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Listeners making specific responses (e.g., wincing, exclaiming)
Trial: 11138763
Drug: Listeners making
RxNorm normalized name: MASK
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Listeners making generic responses (e.g., nodding, vocalizations)
Trial: 19803399
Drug: IV rt‐PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV rt‐PA therapy at a dose of 0.9 mg/kg
Trial: 19803399
Drug: IV rt‐PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV rt‐PA therapy at a dose of 0.6 mg/kg
Trial: 19803399
Drug: IV rt‐PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV rt‐PA administered 3‐4.5 hours after symptom onset
Trial: 19803399
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of reperfusion therapies (IV rt‐PA and sonothrombolysis, neuroprotective agents, or antiplatelet agents)
Trial: 19803399
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of alteplase, combined IV/IA thrombolysis, or mechanical thrombectomy
Trial: 17488248
Drug: Intramuscular octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular octreotide 20 mg (group A) q 4 wk for 3 months
Trial: 14961057
Drug: Clomipramine 25
RxNorm normalized name: clomiPRAMINE 25 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 25 mg as needed
Trial: 14961057
Drug: Clomipramine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine 20 or 30 mg daily
Trial: 12516788
Drug: 75 grams
RxNorm normalized name: vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 75 grams of superactivated charcoal (SAC) administered orally in a slurry 3 hours after acetaminophen dose
Trial: 9862941
Drug: Omeprazole and
RxNorm normalized name: Omeprazole and Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole and antibiotics (20 mg omeprazole orally twice daily, 500 mg amoxicillin three times daily, 400 mg metronidazole three times daily for 2 weeks)
Trial: 9862941
Drug: Omeprazole and
RxNorm normalized name: Omeprazole and Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole and antibiotics
Trial: 9818646
Drug: Non-depleting humanized
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-depleting humanized monoclonal antibody to CD4 (ORTHOCLONE OKTcdr4a) at a dosage of +/-450 mg per week for 2 treatment cycles, followed by a crossover to placebo for the third cycle.
Trial: 2695726
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 1 g claforan given during a period of 24 h (regimen I)
Trial: 2695726
Drug: 1 x
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 x 1 g claforan given at the time of incision (regimen II)
Trial: 2695726
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cefapirin + gentamicin given in divided doses for 5 days (regimen III)
Trial: 719463
Drug: Intravenous load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous load of 11 of Hartmann's solution
Trial: 719463
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intravenous load)
Trial: 28533045
Drug: Animal-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Animal-assisted therapy sessions
Trial: 25593483
Drug: RetroView™ colonoscope
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RetroView™ colonoscope in combination withdrawal (standard + retroflexed)
Trial: 7909525
Drug: N-acetyl-cysteine (NAC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl-cysteine (NAC) treatment
Trial: 11388971
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment need
Trial: 7685687
Drug: Diclofenac/misoprostol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac/misoprostol combination dosage form
Trial: 7685687
Drug: Diclofenac (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (single and multiple doses) in elderly volunteers
Trial: 3718599
Drug: Acemetacin (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acemetacin (90 mg, single administration)
Trial: 3718599
Drug: Acemetacin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acemetacin (2 retard capsules/d for 8 d, multiple administration)
Trial: 24756483
Drug: 2g omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2g omega-3 PUFA daily, initiated 5 days before surgery
Trial: 16555574
Drug: Valsartan (40‐80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (40‐80 mg)
Trial: 31811715
Drug: Ticagrelor 60
RxNorm normalized name: ticagrelor 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor 60 mg or 90 mg plus aspirin
Trial: 31662524
Drug: 10 mg/day
RxNorm normalized name: Adlarity 10 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/day solifenacin
Trial: 23490379
Drug: albIFN 900/1200/1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albIFN 900/1200/1500 μg q4wk
Trial: 23490379
Drug: Peg‐IFNα‐2a 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peg‐IFNα‐2a 180 μg qwk
Trial: 23490379
Drug: oral ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: oral ribavirin 800 mg/d
Trial: 21289240
Drug: Salsalate (4000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (4000 mg Disalsid)
Trial: 19729945
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (BUD) for 4 weeks
Trial: 19729945
Drug: No budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: No budesonide treatment (Control)
Trial: 17239709
Drug: Simvastatin +
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin + Pioglitazone (Combination)
Trial: 15278753
Drug: Oral enzyme‐rutosid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral enzyme‐rutosid combination (ERC)
Trial: 7525170
Drug: Insulin-treated adult
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-treated adult diabetic patients
Trial: 7525170
Drug: Non-insulin-treated adult
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-insulin-treated adult diabetic patients
Trial: 6387568
Drug: Topical 1%
RxNorm normalized name: fluoride topical 1% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 1% indomethacin
Trial: 29701043
Drug: Clomiphene (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene (oral administration for 5 days starting from the 5th day of menstruation or medicine-withdrawal bleeding)
Trial: 12482789
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose lisinopril (32.5 or 35 mg)
Trial: 12482789
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose lisinopril (2.5 or 5 mg)
Trial: 12482789
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of beta blockers or antiarrhythmic agents (mainly amiodarone)
Trial: 12482789
Drug: Long acting
RxNorm normalized name: Long Acting Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long acting nitrates and previous use of angiotensin converting enzyme inhibitors
Trial: 8691702
Drug: Orchiectomy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orchiectomy plus diethylstilbestrol diphosphate plus combination chemotherapy with cisplatin and methotrexate
Trial: 1379883
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg of risperidone daily
Trial: 6381185
Drug: Cimetidine 2.4
RxNorm normalized name: cimetidine 2.4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 2.4 g/day
Trial: 11759022
Drug: Alcoholic gels
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcoholic gels
Trial: 9781721
Drug: cA2 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cA2 (300 mg single dose)
Trial: 7878557
Drug: nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: nedocromil sodium (4 mg) four times daily
Trial: 3226339
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of oestradiol valerate (E2V)
Trial: 17139218
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (short-segment posterior stabilization)
Trial: 14514368
Drug: Comprehensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive treatment (Group B)
Trial: 11192518
Drug: Ferrous sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulfate supplementation (1 mg/kg per day)
Trial: 8472516
Drug: Tablets (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets (600 mg of ST‐679)
Trial: 8472516
Drug: Envelopes (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Envelopes (600 mg of ST‐679)
Trial: 2433901
Drug: Dextran 40
RxNorm normalized name: Dextran 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran 40 (500 ml on admission and on days 1 and 2; 250 ml on days 4 and 6)
Trial: 24987174
Drug: Oral sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sildenafil 25 mg, administered eight hourly for 24 hours before surgery (N = 20)
Trial: 24987174
Drug: Oral sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sildenafil 25 mg
Trial: 22570428
Drug: Orlistat 60
RxNorm normalized name: orlistat 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 60 mg taken up to 3 times daily
Trial: 19890257
Drug: Beta-adrenoceptor antagonist
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenoceptor antagonist propranolol
Trial: 18806024
Drug: Intranasal remifentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal remifentanil (4 mcg/kg)
Trial: 15664480
Drug: Amoxicillin/clavulanate (2000/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (2000/125 mg), given twice daily
Trial: 15664480
Drug: Conventional amoxicillin/clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional amoxicillin/clavulanate formulations (control)
Trial: 15664480
Drug: Amoxicillin/clavulanate (2000/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (2000/125 mg) for PRSP-infected patients
Trial: 12092689
Drug: Active therapy
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active therapy (twice daily insulin injections plus an annual insulin infusion)
Trial: 7479201
Drug: Cefotaxime plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime plus metronidazole (1-g intravenous dose of cefotaxime plus 500-mg oral dose of metronidazole)
Trial: 7479201
Drug: Cefoxitin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (2 g intravenous doses every 6 hours)
Trial: 7479201
Drug: Ampicillin-sulbactam (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin-sulbactam (3 g intravenous doses every 6 hours)
Trial: 20471706
Drug: Digoxin treatment
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin treatment
Trial: 6803946
Drug: Oral cholecystography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cholecystography
Trial: 28817412
Drug: Bodyflow (BF)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bodyflow (BF) therapy
Trial: 28817412
Drug: Deep oscillation
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep oscillation (DO) therapy
Trial: 27712462
Drug: Access therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Access therapy with PRF and 1% ALN gel (group 3)
Trial: 27712462
Drug: Access therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Access therapy alone (group 1)
Trial: 27712462
Drug: Access therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Access therapy with PRF (group 2)
Trial: 17364153
Drug: Laparoscopic transabdominal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic transabdominal preperitoneal patch (TAPP) procedure
Trial: 15383196
Drug: Dose 1
RxNorm normalized name: Aldose 1-epimerase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 1 frovatriptan
Trial: 15383196
Drug: Dose 1
RxNorm normalized name: Aldose 1-epimerase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose 1 placebo
Trial: 10103339
Drug: Abacavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir monotherapy (4 mg/kg every 12 hours for 6 weeks, then 8 mg/kg every 12 hours for 6 weeks)
Trial: 10103339
Drug: Abacavir in
RxNorm normalized name: Product containing abacavir in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir in combination with another antiretroviral agent (8 mg/kg every 12 hours for 12 weeks)
Trial: 10708287
Drug: Abacavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir monotherapy
Trial: 2108254
Drug: Placebo of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo of MgSO4, B complex, and vitamin C in Ringer's lactate solution
Trial: 2108254
Drug: EDTA after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EDTA after initial placebo treatment
Trial: 28910196
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Alpinia galanga (E-AG-01) with caffeine
Trial: 22801247
Drug: Triple oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple oral therapy (metformin, glyburide, and pioglitazone)
Trial: 19592630
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and metformin
Trial: 22801247
Drug: Insulin and
RxNorm normalized name: Isophane insulin and porcine regular insulin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin and metformin (initial therapy)
Trial: 22801247
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (triple oral therapy and insulin/metformin)
Trial: 21359582
Drug: Insulin-based treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-based treatment
Trial: 9541446
Drug: Fucithalmic single
RxNorm normalized name: Fucithalmic
DrugBank: Fusidic acid (DB02703)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fucithalmic single unit dose eye drops
Trial: 24148616
Drug: Oral 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 3% saline
Trial: 23062548
Drug: rHFSC (recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHFSC (recombinant human hyaluronidase-facilitated subcutaneous rehydration)
Trial: 23062548
Drug: IV (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV (intravenous rehydration)
Trial: 15275765
Drug: Oxazepam 15
RxNorm normalized name: oxazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam 15 mg (active placebo)
Trial: 11420167
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose aprotinin (20,000 IU/kg as pretreatment followed by 7500 IU/kg for 6 h)
Trial: 12959274
Drug: BRL 35135
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BRL 35135 8 mg
Trial: 12959274
Drug: Nadolol 20
RxNorm normalized name: nadolol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 20 mg (N20) + BRL 35135 8 mg
Trial: 3549173
Drug: Bitolterol mesylate
RxNorm normalized name: Bitolterol Mesylate
DrugBank: Bitolterol (DB00901)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bitolterol mesylate 1.0 mg
Trial: 3549173
Drug: Bitolterol mesylate
RxNorm normalized name: Bitolterol Mesylate
DrugBank: Bitolterol (DB00901)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bitolterol mesylate 0.5 mg to 3.0 mg
Trial: 3549173
Drug: Bitolterol mesylate
RxNorm normalized name: Bitolterol Mesylate
DrugBank: Bitolterol (DB00901)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bitolterol mesylate >1.0 mg
Trial: 27089542
Drug: Botulinum Toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum Toxin A (BTX) treatment with calf muscle injections every 6 months if needed
Trial: 27089542
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (CO) consisting of firm shoes, night splints, home stretching program, and physiotherapy
Trial: 27089542
Drug: Botulinum Toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum Toxin A (BTX) treatment
Trial: 12111069
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (CO)
Trial: 24225356
Drug: 6-month lipid-based
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month lipid-based nutrient supplement (LNS) providing 108 kcal and other nutrients including vitamin A, vitamin B-12, iron, and zinc at ≥80% of the recommended amounts
Trial: 24225356
Drug: 3-month lipid-based
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month lipid-based nutrient supplement (LNS)
Trial: 20684825
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment after PCI
Trial: 14629243
Drug: Topiramate (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (25 mg per day, with increments to a maximum of 100 mg per day)
Trial: 7795149
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g fish-oil concentrate per day
Trial: 2029123
Drug: Pediazole (ES)
RxNorm normalized name: erythromycin ethylsuccinate / sulfisoxazole Oral Suspension [Pediazole]
DrugBank: Acetyl sulfisoxazole (DB14033)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pediazole (ES) - 50 mg/kg + 150 mg/kg sulfamide, given in three divided doses for ten days
Trial: 2029123
Drug: Cefaclor -
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor - 40-50 mg/kg, given in three divided doses for ten days
Trial: 30372084
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg IR tablet
Trial: 20589148
Drug: Warfarin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin treatment for thromboembolic complications
Trial: 20589148
Drug: Warfarin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin treatment for haemorrhagic complications
Trial: 17342693
Drug: Washout period
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Washout period after treatment
Trial: 14665555
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml of gelatin colloid solution intravenously before surgery
Trial: 14665555
Drug: Conventional i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional i.v. fluid regime with a crystalloid solution (saline)